文献速递消化内镜消化道肿瘤与早癌

早期结直肠癌非治愈性ESD后追加手术与监测的系统综述与重建个体数据Meta分析

Additional Surgery versus Surveillance After Non-curative ESD for Early Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2026-09-09

该系统综述与重建个体数据Meta分析纳入4项研究共815例早期结直肠癌非治愈性ESD后患者,比较追加手术与监测的结局。追加手术与总生存改善相关(HR 0.37,95%CI 0.23-0.59),局部复发更低(RR 0.16,95%CI 0.04-0.63),但癌症特异性生存与远处复发无显著差异。

要点

  • 追加手术改善总生存并降低局部复发。
  • 癌症特异性生存与远处复发无显著差异。
  • 需个体化权衡手术风险与局部复发风险。

核心结论

  • 早期结直肠癌非治愈性ESD后追加手术与总生存改善和局部复发降低相关,癌症特异性生存与远处复发无显著差异。

研究设计与样本

  • 系统检索PubMed、Embase、Web of Science和Cochrane Library至2026年3月25日,纳入比较非治愈性ESD后监测与追加手术的研究。
  • 共纳入4项研究、815例患者,采用随机效应模型,以重建个体数据分析总生存和癌症特异性生存的时间事件终点。

主要发现

  • 追加手术与总生存改善相关(HR 0.37;95%CI 0.23-0.59)。
  • 癌症特异性生存无显著差异(HR 0.63;95%CI 0.26-1.52)。
  • 总体复发无显著差异(RR 0.44;95%CI 0.14-1.38),局部复发追加手术更低(RR 0.16;95%CI 0.04-0.63)。
  • 远处复发无显著差异(RR 0.65;95%CI 0.14-2.93)。

临床怎么用

  • 对非治愈性ESD后的早期结直肠癌患者,应个体化权衡追加手术风险与局部复发风险,并结合患者偏好,尤其对高龄或合并症患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Management after non-curative endoscopic submucosal dissection (ESD) for early colorectal cancer (CRC) remains controversial. We performed a pairwise and reconstructed individual patient data (IPD) meta-analysis to compare outcomes between surveillance and additional surgery. METHODS: A systematic search of PubMed, Embase, Web of Science, and the Cochrane Library was conducted through March 25, 2026. Studies comparing surveillance versus additional surgery after non-curative ESD for CRC were included. Overall survival was the primary outcome and was analyzed as a time-to-event endpoint using reconstructed IPD from published Kaplan-Meier curves. Secondary outcomes included cancer-specific survival (time-to-event), overall recurrence, local recurrence, and distant recurrence. Random-effects models were applied using hazard ratios (HRs) and risk ratios (RRs) with 95% confidence intervals (CIs). RESULTS: Four studies with 815 patients were included. Additional surgery was associated with improved overall survival (HR, 0.37; 95% CI, 0.23-0.59), but not cancer-specific survival (HR, 0.63; 95% CI, 0.26-1.52). Overall recurrence did not differ significantly (RR, 0.44; 95% CI, 0.14-1.38), whereas local recurrence was lower with surgery (RR, 0.16; 95% CI, 0.04-0.63). No difference was observed in distant recurrence (RR, 0.65; 95% CI, 0.14-2.93). CONCLUSION: Additional surgery after non-curative ESD for colorectal cancer is associated with improved overall survival and reduced local recurrence, without significant differences in cancer-specific survival or distant recurrence. These findings highlight the importance of individualized treatment decisions that balance risk of surgery with risk of local recurrence and take into account patient preferences, particularly in patients with advanced age or comorbidities.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Al Hayek M, Sawaf B, Capogreco A, et al. Additional Surgery versus Surveillance After Non-curative ESD for Early Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis. Gastrointest Endosc. 2026. PMID: 42716253. doi:10.1016/j.gie.2026.08.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。